Jeffrey J Brown bought $11k of MED
director at MEDIFAST INC. 155 shares at an average of $69.93, traded Nov 3, 2023, filed Nov 9, 2023.
Score components
- +15RoleDirector
- 0Trade size$11k at market
- 0Relative to holdingsHoldings up 3.7%
- +18Price context2% above the 52-week low; 43% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- -5Track recordMedian 6-month excess return -16% over 9 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +15.4%, 3m -15.7%, 6m -60.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-23-038375, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 3, 2023 | POpen-market purchase Common Stockindirect: Jeffrey Brown Living Trust | +97 | $70.55 | $6,825 | 4,233 | Nov 9, 2023 |
| Nov 7, 2023 | POpen-market purchase Common Stock | +58 | $68.89 | $4,020 | 5,784 | Nov 9, 2023 |
Related signals
Other insiders at MEDIFAST INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | MEDIFAST INC | Daniel R Chard Chairman & CEO | $226k 19,089 shares | -13% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $529k 43,150 shares | +6% | |
| 26Weak | MEDbuy MEDIFAST INC | Parsa Kiai director | $52k 4,329 shares | +1% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $843k 72,487 shares | +12% | |
| 30Weak | MEDbuy MEDIFAST INC | Scott Schlackman director | $63k 5,000 shares | +20% | |
| 63Notable | MEDbuy MEDIFAST INC | Daniel R Chard Chairman & CEO | $179k 17,678 shares | - | |
| 38Weak | MEDbuy MEDIFAST INC | Daniel R Chard Chairman & CEO | $5,003 381 shares | +0% | |
| 21Weak | MEDsell MEDIFAST INC | Scott Schlackman director | $160k 4,053 shares | -34% | |
| 43Moderate | MEDIFAST INC | Michael A. Hoer director | $3,428 50 shares | +1% | |
| 43Moderate | MEDIFAST INC | Scott Schlackman director | $3,627 53 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.